These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9565012)

  • 21. Therapy for early reperfusion after stroke.
    Juttler E; Kohrmann M; Schellinger PD
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):656-63. PubMed ID: 17122798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperacute therapy of ischemic stroke: intravenous thrombolysis.
    Jahan R
    Tech Vasc Interv Radiol; 2005 Jun; 8(2):81-6. PubMed ID: 16194755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acute ischemic stroke: Part I: recanalization strategies.
    Broderick JP; Hacke W
    Circulation; 2002 Sep; 106(12):1563-9. PubMed ID: 12234965
    [No Abstract]   [Full Text] [Related]  

  • 26. TPA within 3 hours of acute ischaemic stroke?
    Dorman P; Sandercock P
    Lancet; 1996 Dec; 348(9042):1600-1. PubMed ID: 8961984
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
    J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombolytic therapy in acute ischemic stroke.
    Frankel MR
    N Engl J Med; 1997 Jan; 336(1):65; author reply 66-7. PubMed ID: 8984332
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuroprotective therapies in stroke.
    Zivin JA
    Drugs; 1997; 54 Suppl 3():83-8; discussion 88-9. PubMed ID: 9360855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Acute embolic stroke treated with rt-PA during elective coronary angiography].
    Ascer E; Lessa I; Caldas JG; Frudit ME; Pereira Mde B; Baruzzi AC
    Arq Bras Cardiol; 1996 Sep; 67(3):171-3. PubMed ID: 9181710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.
    Shiotsuki H; Ogushi Y; Fushimi K; Kobayashi S;
    Tokai J Exp Clin Med; 2005 Apr; 30(1):49-62. PubMed ID: 15952299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombolytic therapy in ischemic cerebrovascular accidents].
    Hommel M; Kumral E; Bogousslavsky J
    Praxis (Bern 1994); 1995 Sep; 84(38):1025-31. PubMed ID: 7481300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Kleindorfer DO; Khatri P; Katzan I
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16353320
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute ischemic stroke therapy. A clinical overview.
    Onal MZ; Fisher M
    Eur Neurol; 1997; 38(3):141-54. PubMed ID: 9363826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel therapies for acute ischemic stroke.
    Leker RR; Eichel R; Rafaeli G; Ben-Hur T
    Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke.
    Schestatsky P; Picon PD
    Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.